Vivus SWEATS for FDA Decision and 3 Stocks Demanding Attention

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

VIVUS, Inc. (NASDAQ:VVUS) is awaiting the FDA’s decision concerning the approval of the company’s diet drug Qnexa. Following its 5.7 percent increase yesterday, shares have fell over 8 percent this morning probably due to anxiety about the decision.  SA author Qineqt advises buying the stock since an approval is probable. Of all of Vivus’ rivals, Orexigen (NASDAQ:OREX) is down 3.11 percent and Arena (NASDAQ:ARNA) is down 2.52 percent. Shares of VIVUS, Inc. are trading 2.6% lower today.

Don’t Miss: Near 20 Year Low: Buy Alcoa or Stay Away?

New Oriental Education & Tech Grp (NYSE:EDU) was told that the U.S. SEC has issued a formal order of investigation captioned “In the Matter of New Oriental Education & Technology Group Inc.” According to the company’s beliefs, the investigation is concerned with whether or not there is a sufficient basis for the consolidation of  Beijing New Oriental Education & Technology Co., Ltd., which is a variable interest entity of the company, and its wholly-owned subsidiaries, into the consolidated financial statements of the company. The company plans to cooperate with the SEC investigation completely. Shares of New Oriental Education & Tech Grp are trading 32.68% lower today.

Vanguard Large-Cap ETF (NYSEARCA:VV): Mega fund managers, like Fidelity Investments, Goldman Sachs, BlackRock Inc., Vanguard Group, and 22 others, each manage between $100 billion and $1 trillion each, together controlling nearly 40 percent of all assets invested in the U.S. equity markets. These mega fund managers remain bullish on the biotech group, which adds a net $4.2 billion in Q1 to their already $117.4 billion before the quarter position within the group. Also, they are all overweight in the group by a 1.2 factor; meaning that, taken together, the company’s have invested 2.0% of all assets in the group, totaling a bit more than the 1.7 percent weighting of the biotech group withing the full market. Shares of Vanguard Large-Cap ETF are trading 0.71% higher today.

Mattel, Inc. (NASDAQ:MAT) reports a 5 percent increase in the Barbie brand for Q2, Fisher-Price Brands is up 2 percent to $407.3 million, and American Girl Brands is up 3 percent to $68.7 million. Shares of Mattel, Inc. are trading 10.66% higher today.

Don’t Miss: Why is Facebook in TROUBLE This Time?

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.

More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business